SCHEMBL5080973

SCHEMBL5080973

COc1ccc2c(ccn2C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.55
HTR2C P28335 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.50
CYP2A6 P11509 2/20 0.50
POLB P06746 1/20 0.50
HTR6 P50406 1/20 0.50
MTNR1A P48039 1/20 0.49
MTNR1B P49286 1/20 0.49
TUBB1 Q9H4B7 2/20 0.48
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48
TUBB8 Q3ZCM7 1/20 0.48
TUBA3E Q6PEY2 1/20 0.48
TUBA1A Q71U36 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444309 1.00 PRKCI (0.55) PRKCIHTR2CL3MBTL1CYP2A6POLB
SCHEMBL29637256 0.85 FAAH (0.58) PRKCICYP2A6TUBB1TUBB4ATUBB
SCHEMBL8685783 0.85 PRKCI (0.52) PRKCIHTR2CL3MBTL1CYP2A6POLB
SCHEMBL3481643 0.84 CYP11B1 (0.50) PRKCIHTR2CL3MBTL1CYP2A6POLB
SCHEMBL1093766 0.84 HTR2A (0.57) HTR2CCYP2A6HTR6MTNR1AMTNR1B
SCHEMBL29869916 0.84 HTR2A (0.57) HTR2CCYP2A6HTR6MTNR1AMTNR1B
SCHEMBL18314120 0.82 PRKCI (0.53) PRKCIHTR2CCYP2A6TUBB1TUBB4A
SCHEMBL7233306 0.82 PRKCI (0.53) PRKCIHTR2CCYP2A6TUBB1TUBB4A
SCHEMBL2656889 0.81 PRKCI (0.52) PRKCIHTR2CCYP2A6TUBB1TUBB4A
SCHEMBL2981004 0.80 NQO2 (0.58) CYP2A6TUBB1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119409615-A 2- (Indol-3-yl) phenol compound and synthesis method thereof 湘潭大学 2025-02-11 CN claimed
CN-117903161-A Tetrathiodiindole compound and derivative, synthetic method and application thereof 衡阳师范学院 2024-04-19 CN claimed
EP-4267564-A1 INDOLE DERIVATIVES USEFUL IN TREATING CONDITIONS ASSOCIATED WITH CGAS Novartis AG (CH) 2023-11-01 EP claimed
CN-116969967-A Synthesis method of polysubstituted-5, 10-dihydro [1,2,3,4] tetrathio [5,6-b:7,8-b' ] diindole and derivative 衡阳师范学院 2023-10-31 CN claimed
CN-116813639-A Synthesis method of polysubstituted [1,2,3,4,5] pentathio [6,7-b ] indole and derivative 衡阳师范学院 2023-09-29 CN claimed
WO-2022137085-A1 INDOLE DERIVATIVES USEFUL IN TREATING CONDITIONS ASSOCIATED WITH CGAS NOVARTIS AG (CH) 2022-06-30 WO claimed
CN-109438318-B Synthesis method of 3-aryl indole and derivatives thereof 湖南医药学院 2022-05-03 CN claimed
CN-107619386-B Aromatic ring [ c ] carbazole derivative and synthesis method thereof 湘潭大学 2020-10-13 CN claimed
CN-106117113-B Polysubstituted carbazole, derivative and its synthetic method 湘潭大学 2019-08-16 CN claimed
CN-106995400-B A kind of compound and its salt and its synthetic method 湘潭大学 2019-08-06 CN claimed
CN-107235990-B Polysubstituted indoles bithiophene and derivative and its synthetic method 湘潭大学 2019-01-29 CN claimed
CN-108218897-A Polysubstituted selenophen diindyl and derivative and its synthetic method 湘潭大学 2018-06-29 CN claimed
CN-107619386-A A kind of aromatic ring simultaneously [c] carbazole analog derivative and its synthetic method 湘潭大学 2018-01-23 CN claimed
CN-107235990-A Polysubstituted indoles bithiophene and derivative and its synthetic method 湘潭大学 2017-10-10 CN claimed
CN-106995400-A A kind of compound and its salt and its synthetic method 湘潭大学 2017-08-01 CN claimed
CN-104788359-A Synthesis method of copper-promoted 3-cyano-substituted-indole compound UNIV HUNAN 2015-07-22 CN claimed
US-12404261-B2 Compounds and compositions for treating conditions associated with cGAS NOVARTIS AG (CH) 2025-09-02 US disclosed
US-20250263760-A1 MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2025-08-21 US disclosed
US-4443615-A ANILINE, GLYCOL OR EPOXIDE, SILICA AND/OR ALUMINA CATALYST TANABE SEIYAKU CO., LTD. (JP) 1984-04-17 US disclosed
EP-0072932-A2 Piperazinones, their preparation and use CASSELLA Aktiengesellschaft (DE) 1983-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12404261-B2 Compounds and compositions for treating conditions associated with cGAS CGAS, TDP1, IAPP PRKCI 1580/4885HTR2C 1303/4885L3MBTL1 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.